CVRX CEO Nadim Yared will be a hard act to follow as AdvaMed chair, as his list of accomplishments over the past two years, as well as his ability to maintain the spotlight on the medtech industry in the US and beyond, have shown. In Kevin Lobo, CEO of Stryker Corp., the industry has a leader who will continue to push back the boundaries for SMEs, as well as developing his own agenda points.
Lobo’s two-year tenure was announced on March 27, and he knows that the 2012 medical device excise tax will continue...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?